Zomedica Launches Truforma Diagnostic Platform for Diagnosis and Management of Cushing’s Disease in Horses
- The TRUFORMA eACTH assay for equine plasma will offer the ability to diagnose and screen equine veterinarians for PPID as well as monitor patients being treated for PPID in their own labs or even stall side in minutes
- The assay can diagnose equine Cushing's Disease or pituitary pars intermedia dysfunction in the clinic or at the stall and monitor positive patients as they titrate therapy
- TRUFORMA is a PoC eACTH assay, compact, easy to use, and durable and perfect for the unique challenges that face equine practitioners
Ref: Accesswire | Image: Zomedica
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at firstname.lastname@example.org
Neha is a Senior Editor at PharmaShots. She is passionate and very enthusiastic about recent updates and developments in the life sciences and pharma industry. She covers Biopharma, MedTech, and Digital health segments along with different reports at PharmaShots. She can be contacted at email@example.com.